Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Enlivex Therapeutics Ltd
ENLVCurrent price
1.76 USD
0 USD (0.00%)
Last closed
1.72 USD
Company
www.enlivex.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
33 477 480 USD
Yield for 12 month
-58.83 %
Week
Month
Year
ENLV
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618
Analytics
WallStreet Target Price
12 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures ENLV
1 year
3 years
5 years
10 years
EBITDA
-26 049 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.18 %
PEG Ratio
–
Return On Equity TTM
-53.23 %
Wall Street Target Price
12 USD
Revenue TTM
–
Book Value
2.09 USD
Revenue Per Share TTM
–
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings Share
-1.47 USD
Diluted Eps TTM
-1.47 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ENLV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ENLV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
06.03.2019
Dividend Date
06.03.2019
Stock Valuation ENLV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.2879
Price Book MRQ
0.8633
Financials ENLV
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators ENLV
For 52 weeks
1.27 USD
4.65 USD
50 Day MA
1.58 USD
Shares Short Prior Month
118 394
200 Day MA
2.52 USD
Short Ratio
2.88
Shares Short
111 104
Short Percent
0.64 %
Google
Apple
Facebook